What is AML?
- AML is a cancer of the bone marrow, which produces red and white blood cells and platelets.
- AML grows in a confined space in the bone marrow, causing the cells that would be producing red and white blood cells and platelets to die off.
- Eventually, the bone marrow begins to fill with these cancer cells.
This so-called factory makes red blood cells that bring oxygen to our tissues; white blood cells that make up the immune system; and platelets, which help stop bleeding, Dr. Sekeres says. All of these cells perform essential functions in the body, and a spike or decline in any of them can lead to some serious health issues.
Read MoreUnderstanding Acute Myeloid Leukemia
Acute myeloid leukemia is a fast-growing blood cancer that begins in the bone marrow, the factory that makes white and red blood cells and platelets.Your blood contains different types of cells:
- White Blood Cells: WBCs are involved in many immune-related processes, but the primary goal of WBCs is to fight infections.
- Red Blood Cells: RBCs are involved in carrying oxygen to the organs of the body.
- Platelets: Platelets are cell fragments that are important for helping blood to clot.
Within the bone marrow are stem cells that eventually develop into WBCs, RBCs and platelets. Stem cells can copy themselves or self renew making progenitor cells or precursor cells. Myeloid progenitor cells turn into red blood cells, granulocytes (a type of white blood cell) and platelets. AML affects the myeloid progenitor cells during a stage of development when they are called myeloblasts. With AML, myeloblasts fail to turn into fully develop blood cells, thus building up in the bone marrow and blood. Also, because the myeloblasts don’t mature, the body lacks RBCs, WBCs and platelets.
According to the National Comprehensive Cancer Network guidelines on AML, to be diagnosed with AML, 20% or more myeloblasts must be present in the blood or bone marrow. (In certain cases, a diagnosis is possible with less than 20%.)
What Are The Risk Factors for Acute Myeloid Leukemia?
For a majority of patients, AML appears out of the blue. But there are some risk factors.
Dr. Gail Roboz, a noted AML expert and medical oncologist at Weill Cornell Medicine, says patients who have undergone chemotherapy and radiation for other forms of cancer can be at increased risk of AML. However, she notes that AML is a rare disease and a majority of cancer patients will not be diagnosed. Dr. Roboz also points out that exposure to organic solvents, such as benzene, are associated with AML, but the association isn't necessarily clear, and doesn't affect treatment options overall.
"One of the things that's actually emerging that as a very important potential predisposition is familial," Dr. Roboz says. "We didn't really used to think of a familial predisposition as important in acute leukemia and yet it might be that up to 10% of leukemias are associated with some sort of familial predisposition."
With this new discovery, people should expect physicians to ask them questions concerning whether family members have had blood disorders, abnormal blood counts, or a history of leukemia.
"That said, the majority of patients have this sporadically or out of the clear blue sky," Dr. Roboz says.
Learn more about SurvivorNet's rigorous medical review process.